AIDOT, a South Korean company specializing in medical AI, announced on July 2 that its medical imaging analysis system, Cerviray A.I., has been newly designated as an innovative product by the Ministry of Trade, Industry and Energy for the first half of 2025.

The designation of innovative products by the Ministry is based on various evaluation criteria, including technological excellence, innovation, and market potential. Products selected are expected to have significant technological and societal impact, and receive active support in public procurement and market expansion.

According to the company, Cerviray A.I. is an AI-powered automatic medical imaging analysis solution that can process and analyze multiple diagnostic imaging data within hospitals.

AIDOT CEO Jaehun Jung said,
“This designation recognizes once again the technological strength and market potential of Cerviray. We will continue to lead the development of AI-based medical solutions, contributing to public health improvement and the advancement of public medical services.”

Digital Today / July 2, 2025 / Reporter Chikyoo Hwang